Supplemental Figure S2 from [18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study

作者：Austin R. Pantel, Sarah B. Gitto, Mehran Makvandi, Hyoung Kim, Sergey Medvedev, Joanna K. Weeks, Drew A. Torigian, Chia‐Ju Hsieh, Benjamin Ferman, Nawar Latif, János L. Tanyi, Lainie P. Martin, Shannon M. Lanzo, Fang Liu, Quy Cao, Gordon B. Mills, Robert K. Doot, David A. Mankoff, Robert H. Mach, Lilie L. Lin, Fiona Simpkins · 年份：2025 · DOI：10.1158/1078-0432.30707132 · 研究领域：PARP inhibition in cancer therapy、Ovarian cancer diagnosis and treatment、Advanced Fluorescence Microscopy Techniques

<p>Time between [18F]FTT imaging scans did not significantly impact SUV measurements.</p>